ABBV vs TECH
By Alex · Tickerpine
AbbVie Inc. vs Bio-Techne Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | TECH |
|---|---|---|
| Price | $253.35 | $71.00 |
| Market cap | $447.62B | $11.06B |
| P/E ratio | 123.6 | 101.4 |
| ROE | — | 5.34% |
| Profit margin | 5.79% | 9.05% |
| Revenue growth | 12.40% | -1.50% |
| Dividend yield | 2.73% | 0.45% |
| Beta | 0.31 | 1.36 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs TECH in plain English
- ABBV is the bigger company — about 40.5× the market cap of TECH.
- TECH is cheaper on earnings (P/E 101.4 vs 123.6).
- ABBV is growing revenue faster (12% vs -2%).
- ABBV has the higher dividend yield (2.73% vs 0.45%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
TECH return calculator
See what $1,000 in Bio-Techne Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.